Skip to content
Shuttingdown

Tevogen Bio Holdings Inc.

Biological Products, (No Diagnostic Substances) · WARREN · NJ

Distress signal

Moderate confidence (50%)

Updated Oct 16, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Tevogen Bio Holdings Inc. received a delisting notice from its exchange (Apr 16, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Tevogen Bio Holdings Inc. received a delisting notice from its exchange

    Apr 16, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 16, 2026, Tevogen Bio Holdings Inc. (the Company ) received a letter from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Company no longer meets Nasdaq s $50 million minimum market value for listed securities requirement pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the MVLS Requirement ) for continued listing on the Nasdaq Global Market based on Nasdaq s review of the market value of the Company s…”

Company information

Founded
—
Employees (estimate)
—
Industry
Biological Products, (No Diagnostic Substances)
Subindustry
—
Listing
SEC lists the tickers TVGN and TVGNW on Nasdaq.
SEC CIK
0001860871
Website
—
LinkedIn
—
Headquarters
WARREN, NJ
Also known as
Semper Paratus Acquisition Corp, Tevogen Bio Holdings Inc.
Legal entities
Tevogen Bio Holdings Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Tevogen Inc. — Biological Products, (No Diagnostic Substances) (SIC 2836) — WARREN, NJ
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 16, 2026, Tevogen Bio Holdings Inc. (the Company ) received a letter from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Company no longer meets Nasdaq s $50 million minimum market value for listed securities requirement pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the MVLS Requirement ) for continued listing on the Nasdaq Global Market based on Nasdaq s review of the market value of the Company s…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:31 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:29 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.